While mainstream AI models are designed to process broad internet data, Semmelweis focuses exclusively on the signals governing prescriptions. By integrating the company's ESPYIAN identity graph, which tracks over six million healthcare professionals, and pulling data from more than 185 electronic health record systems, the model identifies when a physician is actively considering a treatment change rather than simply researching information. This distinction allows the system to orchestrate marketing efforts across different channels without relying on demographic guesswork.

Doceree founder and CEO Harshit Jain named the model after Ignaz Semmelweis, the 19th-century physician whose early insights into infection control were initially rejected by his peers. The company positions its new tool as a way to see clinical signals before they become mainstream trends. Unlike frontier models that operate in a vacuum, Semmelweis functions within a strictly defined compliance architecture. It manages de-identified data and restricts its recommendations to actions that have already cleared medical, legal, and regulatory hurdles. According to co-founder and president Kamya Elawadhi, the model serves as the engine for the company’s new Daily Command operating system, ensuring that every recommendation remains auditable and grounded in specific clinical context. Semmelweis is now live across the Doceree product suite, aiming to shift pharmaceutical marketing metrics away from simple impressions and toward actual therapy outcomes.